Compare Citius Pharmaceuticals Inc (CTXR) vs Wayfair Inc (W) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citius Pharmaceuticals Inc vs Wayfair Inc — how do they compare? Citius Pharmaceuticals Inc trades at $0.53 (market cap $14.64M), while Wayfair Inc trades at $88.76 (market cap $11.71B). The key difference: Wayfair Inc is far larger — about 799.9× Citius Pharmaceuticals Inc's market cap, and Wayfair Inc is trading nearer its 52-week high, Citius Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| CTXR | W | |
|---|---|---|
Market Cap | $14.64M | $11.71B |
Sector | Health | Consumer Cyclical |
52-Week High | $1.82 | $119.05 |
52-Week Low | $0.53 | $53.37 |
Enterprise Value | $10.86M | $14.29B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Wayfair (W) trades at $86.37, down 3.21% today, with a bearish technical signal but strong analyst support. Recent earnings show mixed results, beating estimates in Q3 and Q4 2025 but missing in Q1 2026. The company maintains revenue growth but operates at a net loss, with a negative net income margin of -2.41%. Positive sentiment is driven by expansion into brick-and-mortar stores and AI integration, as highlighted by Bloomberg on July 8, 2026.
The outlook is cautiously optimistic due to a 51.78% buy rating from analysts and a consensus price target of $92.64, offering potential upside. However, risks include persistent unprofitability, high debt-to-asset ratio of 95.11%, and competitive e-commerce pressures. Investors should weigh growth initiatives against financial sustainability amid macroeconomic challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →About Wayfair Inc
Wayfair is a global leader in home goods, operating a massive digital marketplace that connects millions of consumers with thousands of suppliers. It utilizes an asset-light, inventory-light model combined with a proprietary logistics network (CastleGate) and an accelerating brick-and-mortar presence to deliver an end-to-end shopping experience for everything from decor to full home renovations.
Read more on W →
